Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Pharmacokinetic (PK) Exposure of 4-Hydroxycyclophosphamide Associates with Clinical Benefits of Reduced-Dose Post-Transplantation Cyclophosphamide: Results of a Completed Phase I/II Trial to De-Escalate Post-Transplantation Cyclophosphamide for HLA-Haploidentical Myeloablative Bone Marrow Transplantation

Blood (2024) 144 (Supplement 1): 1040.

https://doi.org/10.1182/blood-2024-212138

Published: 2024

Journal Articles

Understanding Barriers to Hematopoietic Cell Transplant (HCT) Access: Socio-Demographic Characteristics and Area Deprivation Index (ADI) of Patients Referred to the National Institutes of Health (NIH) for HCT

Cynthia Eleanya, Stacey Doran, Amy Chai, Rebecca Schwartz, Jessica Andrade, Dimana Dimitrova, Jennifer Hendricks, Mustafa A. Hyder, Rechache Kamil, Ruby Sabina, Jennifer Sponaugle, Christopher G. Kanakry, Jennifer A. Kanakry

Blood (2024) 144 (Supplement 1): 2429.

https://doi.org/10.1182/blood-2024-205625

Published: 2024

Journal Articles

Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation

Meredith J. McAdams, Mustafa Hyder, Dimana Dimitrova, Jennifer L. Sadler, Christi McKeown, Seth M. Steinberg, Amy Chai, Scott Napier, Anita Stokes, Jennifer Sponaugle, Thomas E. Hughes, Nu Ri Cha, Jennifer Cuellar-Rodriguez, Melissa Walker, Ronald E. Gress, Jennifer A. Kanakry, Christopher G. Kanakry

Blood (2021) 138 (Supplement 1): 101.

https://doi.org/10.1182/blood-2021-146997

Published: 2021